Literature DB >> 10870504

Injection drug use and preventive measures: a comparison of Canadian and western European jurisdictions over time.

B Fischer1, J Rehm, T Blitz-Miller.   

Abstract

Mesh:

Year:  2000        PMID: 10870504      PMCID: PMC1232510     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  19 in total

1.  Do needle exchange programmes increase the spread of HIV among injection drug users?: an investigation of the Vancouver outbreak.

Authors:  M T Schechter; S A Strathdee; P G Cornelisse; S Currie; D M Patrick; M L Rekart; M V O'Shaughnessy
Journal:  AIDS       Date:  1999-04-16       Impact factor: 4.177

2.  Needle sharing behaviour among injection drug users (IDUs) in treatment in Montreal and Toronto, 1988-1989.

Authors:  R A Coates; J G Rankin; F Lamothe; R Arshinoff; J Raboud; M E Millson; M L Halliday; J Bruneau; J Soto; J Vincelette
Journal:  Can J Public Health       Date:  1992 Jan-Feb

Review 3.  Can HIV epidemics among injection drug users be prevented?

Authors:  S A Strathdee; E J van Ameijden; F Mesquita; A Wodak; S Rana; D Vlahov
Journal:  AIDS       Date:  1998       Impact factor: 4.177

4.  Enough sterile syringes to prevent HIV transmission among injection drug users in Montreal?

Authors:  R S Remis; J Bruneau; C A Hankins
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1998

Review 5.  Use of sterile syringes and aseptic drug preparation are important components of HIV prevention among injection drug users.

Authors:  T S Jones; D Vlahov
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1998

Review 6.  Syringe exchange in Germany.

Authors:  U Weber; W Schneider
Journal:  Subst Use Misuse       Date:  1998-04       Impact factor: 2.164

Review 7.  Syringe exchange in Canada: good but not enough to stem the HIV tide.

Authors:  C A Hankins
Journal:  Subst Use Misuse       Date:  1998-04       Impact factor: 2.164

8.  Morbidity and mortality attributable to alcohol, tobacco, and illicit drug use in Canada.

Authors:  E Single; L Robson; J Rehm; X Xie; X Xi
Journal:  Am J Public Health       Date:  1999-03       Impact factor: 9.308

Review 9.  Role of maintenance treatment in opioid dependence.

Authors:  J Ward; W Hall; R P Mattick
Journal:  Lancet       Date:  1999-01-16       Impact factor: 79.321

Review 10.  Methadone maintenance treatment: an update.

Authors:  G Bertschy
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1995       Impact factor: 5.270

View more
  17 in total

1.  Interpreting the relation between injection drug use and harm: a cautionary note.

Authors:  J F Anderson
Journal:  CMAJ       Date:  2000-06-13       Impact factor: 8.262

2.  Substance abuse: tempering the debate.

Authors:  P Kendall; E Weir
Journal:  CMAJ       Date:  2000-06-13       Impact factor: 8.262

3.  Unexplained deaths among injection drug users: a case of probable Clostridium myonecrosis.

Authors:  N Williamson; C Archibald; J S Van Vliet
Journal:  CMAJ       Date:  2001-09-04       Impact factor: 8.262

4.  Illicit opioid use in Canada: comparing social, health, and drug use characteristics of untreated users in five cities (OPICAN study).

Authors:  Benedikt Fischer; Jürgen Rehm; Suzanne Brissette; Serge Brochu; Julie Bruneau; Nady El-Guebaly; Lina Noël; Mark Tyndall; Cameron Wild; Phil Mun; Dolly Baliunas
Journal:  J Urban Health       Date:  2005-05-04       Impact factor: 3.671

5.  A description of a peer-run supervised injection site for injection drug users.

Authors:  Thomas Kerr; Megan Oleson; Mark W Tyndall; Julio Montaner; Evan Wood
Journal:  J Urban Health       Date:  2005-05-04       Impact factor: 3.671

6.  Crack use as a public health problem in Canada: call for an evaluation of 'safer crack use kits'.

Authors:  Emma Haydon; Benedikt Fischer
Journal:  Can J Public Health       Date:  2005 May-Jun

7.  Hepatitis C, illicit drug use and public health: does Canada really have a viable plan?

Authors:  Benedikt Fischer; Kate Kalousek; Jürgen Rehm; Jeff Powis; Mel Krajden; Jens Reimer
Journal:  Can J Public Health       Date:  2006 Nov-Dec

8.  Multiple routes of drug administration and HIV risk among injecting drug users.

Authors:  Sigrid Vorobjov; Anneli Uusküla; Don C Des Jarlais; Katri Abel-Ollo; Ave Talu; Kristi Rüütel
Journal:  J Subst Abuse Treat       Date:  2011-11-23

9.  Potential use of safer injecting facilities among injection drug users in Vancouver's Downtown Eastside.

Authors:  Thomas Kerr; Evan Wood; Dan Small; Anita Palepu; Mark W Tyndall
Journal:  CMAJ       Date:  2003-10-14       Impact factor: 8.262

10.  Injection drug use and the hepatitis C virus: considerations for a targeted treatment approach--the case study of Canada.

Authors:  Benedikt Fischer; Emma Haydon; Jürgen Rehm; Mel Krajden; Jens Reimer
Journal:  J Urban Health       Date:  2004-09       Impact factor: 3.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.